“…The Pdgfrb‐Cre line (Foo et al ., 2006), where Cre recombinase expression is driven by a transgenic fragment of the gene for platelet‐derived growth factor receptor β ( Pdgfrb ), has been used extensively to specifically target mural cells, namely vascular smooth muscle cells, pericytes and hepatic stellate cells; examples are given in ref (Abraham et al ., 2008; Foo et al ., 2006; Greif et al ., 2012; Henderson et al ., 2013; Jeansson et al ., 2011; Kogata et al ., 2009; Siegenthaler et al ., 2013; Stenzel et al ., 2009; Ye et al ., 2009; You et al ., 2014). We (Stanczuk et al ., 2015) and others (Klotz et al ., 2015) recently showed that Pdgfrb‐Cre unexpectedly also targets a large proportion of embryonic lymphatic endothelial cells (LECs) in the developing mesentery (Stanczuk et al ., 2015) and the heart (Klotz et al ., 2015).…”